A challenge to the ACCC’s approval of the merger of major payment platforms BPAY, Eftpos and New Payments Platform Australia has been challenged by a Sydney-based fintech, which has accused NPPA of patent infringement.
A judge has adjourned trial in the defamation case by accused war criminal Ben Roberts-Smith to early 2022, saying relocation was not practical after COVID-19 restrictions prevented Fairfax’s witnesses travelling to Sydney.
This week’s judgment referring the conduct of lawyers behind the Banksia class action to prosecutors shows the effectiveness of unique legislative provisions in Victoria that should serve as a blueprint for federal reform, says barrister and University of New South Wales adjunct professor Dr Peter Cashman.
The ACCC has won an interim injunction blocking IVF provider Virtus Health from completing its purchase of rival Adora Fertility on Friday.
A judge has granted law firm Sparke Helmore’s bid for additional security in a negligence lawsuit brought by a property developer, but agreed the $215,000 sought by the firm was excessive.
The High Court has thrown out sacked climate skeptic professor Peter Ridd’s appeal of his dismissal by James Cook University, finding protection of intellectual freedom is not a “general freedom of speech”.
Google has urged a court to stay a competition lawsuit brought by Epic Games, saying new evidence showed the Fortnite game maker would not be disadvantaged if the case was heard in California, as the Full Court found it would in a similar challenge by Apple.
Mining magnate Clive Palmer and two of his mining firms have lost a High Court challenge seeking to overturn a Western Australian law which prevented him from suing the state government for $30 billion over mining tenements in the Pilbara.
A class action over a public housing lockdown during Melbourne’s second COVID-19 wave in July last year is seeking to discontinue battery and negligence claims against the Victorian government, a court has heard.
Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to “leverage” the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.